Efficacy of extracorporeal shock wave therapy in the treatment of lateral epicondylitis

Bayram, Korhan Barış; Yeşil, Hilal; Doğan, Erdal

doi:10.14744/nci.2014.77487

Cited by 7 publications

(6 citation statements)

References 26 publications

(25 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These results indicate that ESWT is a superior therapy compared with US in providing a long-term pain relief in tennis elbow. More importantly, these results were consistent with the previous findings by Rompe et al [28–31]. However, there was high heterogeneity in the pain scores results.…”

Section: Discussionsupporting

confidence: 92%

“…Due to the non-invasive nature and little to no side effects or adverse events associated with ESWT and US, they are preferred by many patients and clinicians as the main adjuvant therapies for tennis elbow [19]. In addition, the efficacy of these two therapies has been supported by a growing number of clinical studies [28–31]. In most cases, either the US or the ESWT is elected per case because of their similar functionality.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

A comparative study of the efficacy of ultrasonics and extracorporeal shock wave in the treatment of tennis elbow: a meta-analysis of randomized controlled trials

et al. 2019

View full text Add to dashboard Cite

Background Tennis elbow or lateral epicondylitis is a common source of pain among craftsmen. Although it cannot be completely resolved, extracorporeal shock wave therapy (ESWT) and ultrasonics (US) have been found to be effective for tennis elbow as highlighted in previously published randomized controlled trials (RCTs) and reviews. However, the efficacy of these two therapies in treating tennis elbow is unknown. This meta-analysis compares the effectiveness of ESWT and US in relieving pain and restoring the functions of tennis elbow following tendinopathy. Methods RCTs published in the PubMed, Embase, Cochrane Library, and SpringerLink databases comparing ESWT and US in treating tennis elbow were identified by a software and manual search. The risk of bias and clinical relevance of the included studies were assessed. Publication bias was explored using funnel plot and statistical tests (Egger’s test and Begg’s test). The major outcomes of the studies were analyzed using the Review Manager 5.3. Results Five RCTs comprising five patients were included in the present meta-analysis. The results revealed a significantly lower VAS score of pain in the ESWT group (1 month: MD = 4.47, p = 0.0001; 3 months: MD = 20.32, p < 0.00001; and 6 months: MD = 4.32, p < 0.0001) compared to US. Besides, the grip strength was markedly higher 3 months after the intervention in ESWT (MD = 8.87, p < 0.00001) than in the US group. Although no significant difference was observed in the scores of the elbow function after 3 months of treatment (SMD = 1.51, p = 0.13), the subjective scores of elbow functions were found to be better in the ESWT group (SMD = 3.34; p = 0.0008) compared to the US group. Conclusions Although there was no significant difference in the elbow function evaluation scores between ESWT and US, the superiority of the ESWT group in the VAS of pain (both at 1 month, 3 months, and 6 months follow-ups) raised grip strength in ESWT group and the scores for subjective evaluation of efficacy indicated that ESWT offers more effective therapy for lateral epicondylitis than US therapy. Electronic supplementary material The online version of this article (10.1186/s13018-019-1290-y) contains supplementary material, which is available to authorized users.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionmentioning

confidence: 99%

A comparative study of the efficacy of ultrasonics and extracorporeal shock wave in the treatment of tennis elbow: a meta-analysis of randomized controlled trials

et al. 2019

View full text Add to dashboard Cite

show abstract

“…The results of the studies investing ESWT treatment of lateral epicondylitis affected patients are controversial. Similar to other authors [39][40][41], Pettrone et al [42], in a study involving 114 patients, obtained satisfying results in the management of epicondylitis with ESWT (vs. a placebo group). When an ultrasonography-guided [43] approach was used, the authors reported a positive response in 75.7% of the patients after the first treatment.…”

Section: Lateral Epicondylitis (Lep)supporting

confidence: 76%

Extracorporeal Shockwave Therapy Treatment in Upper Limb Diseases: A Systematic Review

Testa

Vescio

Perez

et al. 2020

JCM

View full text Add to dashboard Cite

Background: Rotator cuff tendinopathy (RCT), subacromial impingement (SAIS), and medial (MEP) and lateral (LEP) epicondylitis are the most common causes of upper limb pain caused by microtrauma and degeneration. There are several therapeutic choices to manage these disorders: extracorporeal shockwave therapy (ESWT) has become a valuable option. Methods: A systematic review of two electronic medical databases was performed by two independent authors, using the following inclusion criteria: RCT, SAIS, MEP, and LEP, ESWT therapy without surgical treatment, with symptoms duration more than 2 months, and at least 6 months of follow-up. Studies of any level of evidence, reporting clinical results, and dealing with ESWT therapy and RCT, SAIS, MEP, and LEP were included. Results: A total of 822 articles were found. At the end of the first screening, following the previously described selection criteria, we selected 186 articles eligible for full-text reading. Ultimately, after full-text reading, and reference list check, we selected 26 articles following previously written criteria. Conclusions: ESWT is a safe and effective treatment of soft tissue diseases of the upper limbs. Even in the minority cases when unsatisfied results were recorded, high energy shockwaves were nevertheless suggested in prevision of surgical treatment.

show abstract

“…In a case-control study, Pettrone et al [32] described successful results of patients managed with ESWT, compared to the placebo group, with a reduction of the VAS score from 74 ± 15.8 baseline to 37.6 ± 28.7 post-treatment after 12 weeks, and at the same follow-up an improvement of functional outcome (p < 0.01 respect the baseline). Bayram et al [6] reported a decrease of pain at the rest, compression and activities 1-month after the treatment compared to baseline (PRTEE pretreatment = 91.50 ± 11.24; PRTEE post-treatment = 55.83 ± 11.69); interestingly Köksa et al [22] showed a decrease of pain symptomatology while resting, stretching, working, and nighttime pain just after 2 weeks of shockwaves. Speed et al [33] evaluated the comparison between the treatment of ESWT in patients affected by LE of a least 3 months and a placebo group, but contrary to previous studies, their data showed a 35% successful outcome in the ESWT group and 34% in the placebo group, with no differences between the cohort.…”

Section: Discussionmentioning

confidence: 97%

“…Mill's test and Cozen's test [6]. In addition, LE can be confirmed by musculoskeletal ultrasound [7].…”

Section: Introductionmentioning

confidence: 91%

Functional Outcome at Short and Middle Term of the Extracorporeal Shockwave Therapy Treatment in Lateral Epicondylitis: A Case-Series Study

Testa

Vescio

Perez

et al. 2020

JCM

View full text Add to dashboard Cite

Lateral epicondylitis (LE) of the humerus is a chronic degeneration of wrist extensor tendons at their attachments to the lateral epicondyle of the humerus. There is not a common consensus on a specific therapeutic algorithm, but Extracorporeal Shockwave Therapy (ESWT) is widely used. The purpose of this study is to evaluate the clinical benefits of low dose ESWT in LE-affected patients in short and medium follow-up. Between January 2015 and December 2017, 60 patients (38 male, mean age 52.2 ± 10.1 years, the duration of the disease was 3.6 ± 1.3 months) were clinically evaluated using visual analog scale (VAS) and Patient Rated Tennis Elbow Evaluation Test (PRTEE-I) scores before treatment, at one, three, six and 12 months after treatment. According to the VAS and PRTEE-I scoring systems, all patients achieved an improvement of pain and functional outcome comparing the baseline results with one, six and 12 months values. Low dose ESWT is a safe and effective treatment of LE in the short and middle term. In elderly subjects, patients with a long disease history, or those with occupational and sportive risk factors, a longer persistence of the symptomatology could be observed.

show abstract

Efficacy of extracorporeal shock wave therapy in the treatment of lateral epicondylitis

Cited by 7 publications

References 26 publications

A comparative study of the efficacy of ultrasonics and extracorporeal shock wave in the treatment of tennis elbow: a meta-analysis of randomized controlled trials

A comparative study of the efficacy of ultrasonics and extracorporeal shock wave in the treatment of tennis elbow: a meta-analysis of randomized controlled trials

Extracorporeal Shockwave Therapy Treatment in Upper Limb Diseases: A Systematic Review

Functional Outcome at Short and Middle Term of the Extracorporeal Shockwave Therapy Treatment in Lateral Epicondylitis: A Case-Series Study

Contact Info

Product

Resources

About